10 most popular complementary medicines may interact with cancer therapy
the ONA take:
According to new research presented at the Clinical Oncology Society of Australia's (COSA's) Annual Scientific Meeting in Melbourne, Australia, researchers at Peter MacCallum Cancer Centre in Melbourne have found that the 10 most asked about complementary medicines all may result in drug interactions with administered with chemotherapy, radiation, or prior to surgery.
For the study, researchers identified the 10 most commonly inquired about complementary medicines by providers and patients to the hospital's Medicines Information Centre. Excluding vitamins and minerals, the 10 most commonly asked about complementary medicines were: astragalus, coenzyme Q10, fish oil, ginger, green tea, lactobacillus, licorice, milk thistle, and reishi mushroom.
The researchers note that any of those found in a normal healthy diet would not likely cause adverse effects, but higher quantities consumed in complementary medicines could. These supplemental medicines have the potential to alter the effects of chemotherapy, thereby increasing the patient's risk of toxicity or decreasing the effectiveness of the chemotherapy.
Products that contain high levels of antioxidants can potentially interact with chemotherapy and radiotherapy. Patients should be aware that a natural product may not be safe and a complementary product does not necessarily complement standard cancer therapies.
10 most asked about complementary medicines all may result in drug interactions.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|